<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957668</url>
  </required_header>
  <id_info>
    <org_study_id>19-04-0392</org_study_id>
    <nct_id>NCT03957668</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation</brief_title>
  <official_title>Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fakultas Kedokteran Universitas Indonesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PT Meiji Indonesia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fakultas Kedokteran Universitas Indonesia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the efficacy and safety of PEG 3350 (polyethylene
      glycol 3350) for short-term treatment of chronic constipation in adults.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of number of bowel movements at 1 week</measure>
    <time_frame>7 days</time_frame>
    <description>An increase in the number of bowel movements (defecation) per 7-day period indicates a positive result.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of number of bowel movements at 2 weeks</measure>
    <time_frame>14 days</time_frame>
    <description>An increase in the number of bowel movements (defecation) per 7-day period indicates a positive result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom scores at 1 week</measure>
    <time_frame>7 days</time_frame>
    <description>Stool consistency: 0 = hard, 1 = firm, 2 = soft, 3 = loose, 4 = watery (by anamnesis - visual comparison)
Stool passage: 0 = strain, 1 = easy, 2 = loss of control (by anamnesis)
Cramping and rectal irritation associated with each bowel movement: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = have to discontinue (by anamnesis)
Flatus: 0 = none, 1 = moderate, 2 = occasional, 3 = frequent, 4 = very frequent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom scores at 2 weeks</measure>
    <time_frame>14 days</time_frame>
    <description>Stool consistency: 0 = hard, 1 = firm, 2 = soft, 3 = loose, 4 = watery (by anamnesis - visual comparison)
Stool passage: 0 = strain, 1 = easy, 2 = loss of control (by anamnesis)
Cramping and rectal irritation associated with each bowel movement: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = have to discontinue (by anamnesis)
Flatus: 0 = none, 1 = moderate, 2 = occasional, 3 = frequent, 4 = very frequent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall rating of effectiveness at 1 week</measure>
    <time_frame>7 days</time_frame>
    <description>Effective: patients with ≥ 3 bowel movements per 7-day period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall rating of effectiveness at 2 weeks</measure>
    <time_frame>14 days</time_frame>
    <description>Effective: patients with ≥ 3 bowel movements per 7-day period</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of participants with adverse events (AEs)</measure>
    <time_frame>7 days, 14 days</time_frame>
    <description>The following adverse events may occur after treatment, thus will be evaluated:
Headache
Dizziness
Fatigue
Weakness
Nausea
Dry mouth
Abdominal pain / cramping
Flatulence
Rectal irritation
Diarrhea / watery stool</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of participants with serious adverse events (SAEs)</measure>
    <time_frame>7 days, 14 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Constipation - Functional</condition>
  <arm_group>
    <arm_group_label>PEG 3350</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The content of each sachet of PEG 3350 (17 g powder) is dissolved in 240 mL of water, drink it once daily at bedtime, for a duration of 14 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactulax</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 ml of Lactulax syrup (containing 10 g of lactulose) is drunk with 240 ml of water once daily at bedtime, for a duration of 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG 3350</intervention_name>
    <description>PEG 3350 17 g once daily for 14 days</description>
    <arm_group_label>PEG 3350</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactulose</intervention_name>
    <description>Lactulose 10 g once daily for 14 days</description>
    <arm_group_label>Lactulax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females aged ≥ 18 years.

          2. Body Mass Index (BMI) ≥ 18.5

          3. Organic bowel disease will be ruled out by Fecal Immunochemical Test (FIT) and/or
             colonoscopy.

          4. Must have ≤ 2 bowel movements during a 7-day qualification period.

          5. In otherwise good health as judged by a physical examination and laboratory testing.

          6. Not taking medications known to affect bowel function in one week before study.

          7. Willing to participate in the study by signing the informed consent.

        Exclusion Criteria:

          1. Hypersensitive to the study medication.

          2. obstructive ileus.

          3. Irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murdani Abdulah</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fakultas Kedokteran Universitas Indonesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Murdani Abdullah</last_name>
    <phone>+628129550812</phone>
    <email>kolitgastro@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Puskesmas Kelurahan Petamburan</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10260</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Puskesmas Kelurahan Paseban</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10440</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fakultas Kedokteran Universitas Indonesia</investigator_affiliation>
    <investigator_full_name>Murdani Abdullah</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>PEG 3350</keyword>
  <keyword>Constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactulose</mesh_term>
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03957668/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

